» Articles » PMID: 23956492

Synthesis and Characterization of Salicylic Acid-Based Poly(Anhydride-Ester) Copolymers

Overview
Publisher Sage Publications
Date 2013 Aug 20
PMID 23956492
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

A series of poly(anhydride-esters) based on poly(1,10-bis(-car-boxyphenoxy)decanoate) (CPD) and poly(1,6-bis(-carboxyphenoxy)hexane) (-CPH) were synthesized by melt-condensation polymerization. Poly-(anhydride-esters) that contain CPD hydrolytically degraded into salicylic acid, however, these homopolymers have mechanical and thermal characteristics that limit their use in clinical applications. The synthesis and characterization of copolymers of CPD with -CPH, a monomer known to generate mechanically stable homopolymers, was investigated. By changing the CPD to -CPH monomer ratios, the salicylic acid loading and thermal/mechanical properties of the copolymers was a controlling factor; increasing the CPD concentration increased the salicylate loading but decreased the polymer stability; whereas increasing the -CPH concentration increased the thermal and mechanical stability of the copolymers. Specifically, decreasing the CPD:-CPH ratio resulted in lower salicylate loading and increased thermal decomposition temperatures. The glass transition temperatures (°C) varied from 27 to 38°C, a desirable range for elastomeric biomedical implants.

Citing Articles

Degradable Polymer Films Made from Poly(salicylic-acid--sebacic acid) and Poly(sebacic anhydride)/Poly(adipic anhydride) Blends: Degradation Kinetics and Use as Sacrificial Layers for Polymer Multilayer Systems.

Deng Z, Riga E, Lienkamp K Macromol Chem Phys. 2021; 221(12).

PMID: 34646086 PMC: 7611817. DOI: 10.1002/macp.202000106.


Inhibition of BMP9 Induced Bone Formation by Salicylic-acid Polymer Capping.

Acri T, Laird N, Hong L, Chakka J, Shin K, Elangovan S MRS Adv. 2021; 4(64):3505-3512.

PMID: 33912355 PMC: 8078835. DOI: 10.1557/adv.2020.61.


Poly(anhydride-ester) gemcitabine: Synthesis and particle engineering of a high payload hydrolysable polymeric drug for cancer therapy.

Heyder R, Sunbul F, Almuqbil R, Fines C, da Rocha S J Control Release. 2020; 330:1178-1190.

PMID: 33212118 PMC: 10939058. DOI: 10.1016/j.jconrel.2020.11.025.


Salicylic Acid-Based Polymers for Guided Bone Regeneration Using Bone Morphogenetic Protein-2.

Subramanian S, Mitchell A, Yu W, Snyder S, Uhrich K, OConnor J Tissue Eng Part A. 2015; 21(13-14):2013-24.

PMID: 25813520 PMC: 4507132. DOI: 10.1089/ten.TEA.2014.0455.


PolyMorphine: an innovative biodegradable polymer drug for extended pain relief.

Rosario-Melendez R, Harris C, Delgado-Rivera R, Yu L, Uhrich K J Control Release. 2012; 162(3):538-44.

PMID: 22877734 PMC: 3455147. DOI: 10.1016/j.jconrel.2012.07.033.


References
1.
Alam H, Burris D, Dacorta J, Rhee P . Hemorrhage control in the battlefield: role of new hemostatic agents. Mil Med. 2005; 170(1):63-9. DOI: 10.7205/milmed.170.1.63. View

2.
Su S . Novel coating to reduce medical device encrustation. Med Device Technol. 2004; 15(1):12-4. View

3.
Prudencio A, Schmeltzer R, Uhrich K . Effect of Linker Structure on Salicylic Acid-Derived Poly(anhydride-esters). Macromolecules. 2013; 38(16):6895-6901. PMC: 3748625. DOI: 10.1021/ma048051u. View

4.
Darouiche R . Treatment of infections associated with surgical implants. N Engl J Med. 2004; 350(14):1422-9. DOI: 10.1056/NEJMra035415. View

5.
Gopferich A . Mechanisms of polymer degradation and erosion. Biomaterials. 1996; 17(2):103-14. DOI: 10.1016/0142-9612(96)85755-3. View